The patient had been treated with conventional fractionation to bilateral breasts in the past as treatment for her synchronous IDC.
She is currently intolerant of multi-agent chemo and is not a surgical candidate.
Would you consider "definitive" re-irradiation, and if so, what dose and fractionation?
For additional reading, see JCO OGR 11/2021 by @Laura Warren and @Jennifer R. Bellon reviewing landscape of adjuvant treatment after lumpectomy for DCIS, and companion study with longterm outcomes from RTOG 9804 (@Beryl McCormick et al).